Literature DB >> 24291656

Gene-body mass index interactions are associated with methotrexate toxicity in rheumatoid arthritis.

Stella Aslibekyan1, Jin Sha, David T Redden, Larry W Moreland, James R O'Dell, Jeffrey R Curtis, Ted R Mikuls, Richard J Reynolds, Maria I Danila, S Louis Bridges.   

Abstract

Entities:  

Keywords:  Gene Polymorphism; Methotrexate; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2013        PMID： 24291656      PMCID： PMC3970399          DOI： 10.1136/annrheumdis-2013-204263

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

Review 1.  2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Authors:  Jasvinder A Singh; Daniel E Furst; Aseem Bharat; Jeffrey R Curtis; Arthur F Kavanaugh; Joel M Kremer; Larry W Moreland; James O'Dell; Kevin L Winthrop; Timothy Beukelman; S Louis Bridges; W Winn Chatham; Harold E Paulus; Maria Suarez-Almazor; Claire Bombardier; Maxime Dougados; Dinesh Khanna; Charles M King; Amye L Leong; Eric L Matteson; John T Schousboe; Eileen Moynihan; Karen S Kolba; Archana Jain; Elizabeth R Volkmann; Harsh Agrawal; Sangmee Bae; Amy S Mudano; Nivedita M Patkar; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

2.  A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial.

Authors:  Larry W Moreland; James R O'Dell; Harold E Paulus; Jeffrey R Curtis; Joan M Bathon; E William St Clair; S Louis Bridges; Jie Zhang; Theresa McVie; George Howard; Désirée van der Heijde; Stacey S Cofield
Journal:  Arthritis Rheum       Date:  2012-09

3.  Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis.

Authors:  Thierry Dervieux; Judith A M Wessels; Joel M Kremer; Leonid Padyukov; Maria Seddighzadeh; Saedis Saevarsdottir; Ronald F van Vollenhoven; Lars Klareskog; Tom W Huizinga; Henk-Jan Guchelaar
Journal:  Pharmacogenet Genomics       Date:  2012-01       Impact factor: 2.089

4.  Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.

Authors:  J J Haringman; T J M Smeets; P Reinders-Blankert; P P Tak
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

5.  Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.

Authors:  Peter D Kent; Harvinder S Luthra; Clement Michet
Journal:  J Rheumatol       Date:  2004-09       Impact factor: 4.666

6.  Roles of chemokine ligand-2 (CXCL2) and neutrophils in influencing endothelial cell function and inflammation of human adipose tissue.

Authors:  Christine Rouault; Vanessa Pellegrinelli; Raphaela Schilch; Aurélie Cotillard; Christine Poitou; Joan Tordjman; Henrike Sell; Karine Clément; Danièle Lacasa
Journal:  Endocrinology       Date:  2013-01-31       Impact factor: 4.736

7.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962
  7 in total
  3 in total

Review 1.  Preventive Treatments for Rheumatoid Arthritis: Issues Regarding Patient Preferences.

Authors:  Axel Finckh; Monica Escher; Matthew H Liang; Nick Bansback
Journal:  Curr Rheumatol Rep       Date:  2016-08       Impact factor: 4.592

Review 2.  Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis.

Authors:  Xiu-Min Chen; Run-Yue Huang; Qing-Chun Huang; Yong-Liang Chu; Jing-Yao Yan
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-24       Impact factor: 2.629

Review 3.  Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search.

Authors:  Nadia M T Roodenrijs; Paco M J Welsing; Joël van Roon; Jan L M Schoneveld; Marlies C van der Goes; György Nagy; Michael J Townsend; Jacob M van Laar
Journal:  Rheumatology (Oxford)       Date:  2022-08-30       Impact factor: 7.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.